<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Style-Type" content="text/css" /><meta name="generator" content="Aspose.Words for .NET 13.4.0.0" /><title>/</title></head><body><div><p style="margin:0pt"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt; text-align:center"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Written evidence from Ovarian Cancer Action (PHE000</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">8</span><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">)</span></p><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Overview:</span></p><ol type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold; line-height:115%; margin:0pt 0pt 0pt 32pt; padding-left:4pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Introduction</span></li></ol><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 64.52pt; padding-left:7.48pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">The aims of Ovarian Cancer Action: research and awareness raising.</span></li></ul><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><ol start="2" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold; line-height:115%; margin:0pt 0pt 0pt 32pt; padding-left:4pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Public Health England and ovarian cancer: responsibilities</span></li></ol><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 64.52pt; padding-left:7.48pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">Ovarian Cancer Action has made proposals around four of Public Health England’s core responsibilities.  </span></li><li style="font-family:Symbol; font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 64.52pt; padding-left:7.48pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">Key amongst these are proposals relating to symptoms awareness, early diagnosis, data collection and treatment options.</span></li></ul><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">&#xa0;</span></p><ol start="3" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold; line-height:115%; margin:0pt 0pt 0pt 32pt; padding-left:4pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Public Health England and ovarian cancer: priorities</span></li></ol><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 64.52pt; padding-left:7.48pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">Addressing health issues around ovarian cancer meets the priorities of Public Health England for 2013-2014.</span></li></ul><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><ol start="4" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold; line-height:115%; margin:0pt 0pt 0pt 32pt; padding-left:4pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">Further information</span></li></ol><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 64.52pt; padding-left:7.48pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">Contact Ovarian Cancer Action for further information on the issues addressed in this paper.</span></li></ul><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt 36pt"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">&#xa0;</span></p><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt"><a name="_GoBack"></a><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">1. Introduction</span></p><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:12pt">Ovarian Cancer Action strives to stop women in the UK dying from ovarian cancer.  We fund world-class scientific research to improve accurate and earlier detection of ovarian cancer, more effective treatments to combat the disease and improved quality of life after diagnosis.</span></p><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:12pt">Ovarian Cancer Action campaigns to ensure women and healthcare providers know risk factors, symptoms and treatment options to enable informed and rapid action.  Fundamentally we demand that every woman should have the best treatment available. </span></p><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">2. Public Health England and ovarian cancer: responsibilities</span></p><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:12pt">Public Health England (PHE) is tasked with the mission to protect and improve the nation’s health and to address inequalities.  PHE can play a pivotal role in enabling the public to be better informed about the symptoms and diagnosis of ovarian cancer, and the role of genetic testing in early detection and prevention.  Only through systemic changes will improvements be made in the way ovarian cancer is researched, diagnosed, treated and potentially prevented.</span></p><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:12pt">We have addressed four of the key responsibilities of Public Health England and submit our proposals for action:</span></p><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">2A. Supporting the public so they can protect and improve their own health.</span></p><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:12pt">Diagnosis</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 28.52pt; padding-left:7.48pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">Every woman should know the symptoms of ovarian cancer.  Every two hours a woman in the UK dies of ovarian cancer, yet symptoms awareness is poor and a third of women with the disease are diagnosed as an emergency admission.</span></li><li style="font-family:Symbol; font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 28.52pt; padding-left:7.48pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">GPs and healthcare providers need to understand the symptoms and the need for rapid diagnosis.  </span></li><li style="font-family:Symbol; font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 28.52pt; padding-left:7.48pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">Early detection can significantly improve the chance of survival.</span></li><li style="font-family:Symbol; font-size:12pt; line-height:115%; margin:0pt 0pt 10pt 28.52pt; padding-left:7.48pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">Women with ovarian cancer should be offered BRCA1&amp; BRCA2 testing at the point of diagnosis as this can impact their treatment path.</span></li></ul><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:12pt">Prevention</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 28.52pt; padding-left:7.48pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">Women with a family history of breast and ovarian cancer should have straightforward access to genetic testing.  </span></li><li style="font-family:Symbol; font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 28.52pt; padding-left:7.48pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">Adopted children should have access to genetic information about their biological parents.</span></li><li style="font-family:Symbol; font-size:12pt; line-height:115%; margin:0pt 0pt 10pt 28.52pt; padding-left:7.48pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">If a woman knows that she has a BRCA1/2 gene mutation she should have access to advice and preventative surgery if desired.  </span></li></ul><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">2B. Researching, collecting and analysing data to improve our understanding of health and come up with answers to public health problems.</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 28.52pt; padding-left:7.48pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">We require more information on the extent of implementation of the NICE guidelines on the diagnosis of ovarian cancer.  This includes the number of CA125 tests commissioned in relation to the stage at which each patient is diagnosed with ovarian cancer.</span></li><li style="font-family:Symbol; font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 28.52pt; padding-left:7.48pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">More data is needed on the numbers of women with progression free survival after five years.</span></li><li style="font-family:Symbol; font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 28.52pt; padding-left:7.48pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">Hospital-specific data should be published on the outcomes of surgery and survival rates post five years.</span></li><li style="font-family:Symbol; font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 28.52pt; padding-left:7.48pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">More comprehensive comparative data between </span><span style="font-family:'Times New Roman'; font-size:12pt">oophorectomy</span><span style="font-family:'Times New Roman'; font-size:12pt"> and </span><span style="font-family:'Times New Roman'; font-size:12pt">salpingectomy</span><span style="font-family:'Times New Roman'; font-size:12pt"> in women with BRCA1/2 gene mutations or strong family history is required.  </span></li><li style="font-family:Symbol; font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 28.52pt; padding-left:7.48pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">Ovarian cancer has a high level of recurrence and with repeated rounds of chemotherapy the recurrent disease becomes treatment resistant. Tumours should be biopsied at the time of diagnosis and at subsequent recurrence to enable better understanding, and reversal, of the problem of platinum resistance.</span></li><li style="font-family:Symbol; font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 28.52pt; padding-left:7.48pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">A number of studies conclude that current use of the contraceptive pill can protect women from ovarian cancer while slightly increasing the risks of some other cancers.  We would welcome a systematic review and set of public recommendations.</span></li><li style="font-family:Symbol; font-size:12pt; line-height:115%; margin:0pt 0pt 10pt 28.52pt; padding-left:7.48pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">There is an outstanding level of co-operation and willingness to share ideas amongst those in the ovarian cancer research field worldwide.  Fostering scientific collaboration and knowledge sharing is core to our philosophy.  Data should be made available to scientists globally and be open-source. </span></li></ul><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">2C. Reporting on improvements in the public’s health so everyone can understand the challenge and the next steps.</span></p><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:12pt">Public Health England has a role in publicising both improvements and deteriorations in the public’s health.  The Office for National Statistics recently published cancer survival statistics which, although pointing to minor improvements in five year survival rates for ovarian cancer, acknowledged that survival in England at one and five years was generally lower than in other comparably wealthy countries.  </span></p><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:12pt">Information such as this must be recognised and action taken to change outcomes.</span></p><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic; font-weight:bold">2D. Helping local authorities and the NHS to develop the public health system and its specialist workforce.  </span></p><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:12pt">Treatment</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 28.52pt; padding-left:7.48pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">Women in the UK deserve the best quality treatment the world has to offer, in major specialist centres.  </span></li><li style="font-family:Symbol; font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 28.52pt; padding-left:7.48pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">All women with ovarian cancer should be seen by a specialist surgeon and have the options for radical surgery discussed with them.</span></li><li style="font-family:Symbol; font-size:12pt; line-height:115%; margin:0pt 0pt 0pt 28.52pt; padding-left:7.48pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">Women with ovarian cancer should be given the best possible information on therapeutic options and service providers in order to make informed choices.  </span></li><li style="font-family:Symbol; font-size:12pt; line-height:115%; margin:0pt 0pt 10pt 28.52pt; padding-left:7.48pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:12pt">After treatment patients should have support on their psychosocial and sexual wellbeing as standard.</span></li></ul><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">3. Public Health England and ovarian cancer: priorities</span></p><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:12pt">Amongst PHE’s priorities for 2014 is promoting the development of place-based public health systems.  Ovarian Cancer Action recommends that women are treated by expert clinical staff in major specialist centres.  Information about the outcomes of treatment at these centres must be made freely available.</span></p><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:12pt; font-weight:bold">4. Further information</span></p><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:12pt">Ovarian Cancer Action would be glad to answer any questions the Health Select Committee has.  We can contribute a specific report on the benefits of rapid genetic testing for families affected by BRCA1/2 gene mutations and the implications for treating and preventing ovarian cancer. </span></p><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:12pt">&#xa0;</span></p><p style="font-size:12pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:'Times New Roman'; font-size:12pt; font-style:italic">November 2013</span></p><p style="margin:0pt; text-align:right"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p></div></body></html>